OVID
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 06 Jun 2023)
What this means for you
Registered since 06 Dec 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86460338
- Registration number
- 5096037
- Mark type
- Stylized text
- Filed
- 20 Nov 2014
- Published for opposition
- 21 Jul 2015
- Registered
- 06 Dec 2016
- Attorney of record
- Danny M. Awdeh
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical Research and Development of therapies for * rare neurological * diseases of the brain
Owner
- Ovid Therapeutics Inc., New York, NY, US
- Ovid Therapeutics Inc., New York, NY, US
- Ovid Therapeutics Inc., Weston, CT, US
Prosecution history
- 06 Dec 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Jun 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Nov 2022 — TEAS SECTION 8 & 15 RECEIVED
- 06 Dec 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Dec 2018 — TTAB RELEASE CASE TO TRADEMARKS
- 06 Dec 2018 — CANCELLATION TERMINATED NO. 999999
- 03 Dec 2018 — AMENDMENT UNDER SECTION 7 - PROCESSED
- 29 Nov 2018 — CANCELLATION DENIED NO. 999999
- 07 Sept 2017 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 07 Sept 2017 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 31 Jul 2017 — CANCELLATION INSTITUTED NO. 999999
- 06 Dec 2016 — REGISTERED-PRINCIPAL REGISTER
- 29 Oct 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED